Cognition Therapeutics Inc (CGTX)

Dec 23, 2025

Earnings Risk: Why Cognition Therapeutics Inc stock could outperform in 2025Earnings Summary Report & Community Consensus Stock Picks - moha.gov.vn

Dec 23, 2025

Dec 21, 2025

How Cognition Therapeutics Inc. stock reacts to oil prices2025 Earnings Impact & Daily Technical Stock Forecast Reports - Улправда

Dec 21, 2025

Dec 19, 2025

Why Cognition Therapeutics Inc. stock could outperform in 20252025 Trading Recap & Daily Oversold Stock Bounce Ideas - bolumsonucanavari.com

Dec 19, 2025

Dec 18, 2025

[8-K] COGNITION THERAPEUTICS INC Reports Material Event | CGTX SEC FilingForm 8-K - Stock Titan

Dec 18, 2025

Dec 18, 2025

Cognition Therapeutics Launches New $75M ATM Offering - TipRanks

Dec 18, 2025

Dec 18, 2025

Growth Value: How Cognition Therapeutics Inc. stock reacts to oil prices2025 Short Interest & Daily Profit Maximizing Tips - Улправда

Dec 18, 2025

Dec 18, 2025

[S-3] COGNITION THERAPEUTICS INC Shelf Registration Statement | CGTX SEC FilingForm S-3 - Stock Titan

Dec 18, 2025

Dec 18, 2025

Cognition Therapeutics launches new $75M ATM offering - MSN

Dec 18, 2025

Dec 17, 2025

Cognition Therapeutics, Inc. (NASDAQ:CGTX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Dec 17, 2025

Dec 05, 2025

Will Cognition Therapeutics (NASDAQ:CGTX) Spend Its Cash Wisely? - Yahoo Finance

Dec 05, 2025

Dec 05, 2025

Cognition Therapeutics (NASDAQ:CGTX) Earns "Buy" Rating from HC Wainwright - MarketBeat

Dec 05, 2025

Dec 05, 2025

Why retail investors pile into Cognition Therapeutics Inc. stock2025 Growth vs Value & Daily Momentum Trading Reports - Newser

Dec 05, 2025

Dec 04, 2025

HC Wainwright & Co. Reiterates Cognition Therapeutics (CGTX) Buy Recommendation - Nasdaq

Dec 04, 2025

Dec 04, 2025

CGTX Analyst Rating: HC Wainwright & Co. Maintains Buy Rating | - GuruFocus

Dec 04, 2025

Dec 04, 2025

Why Cognition Therapeutics Inc. stock is favored by pension fundsJuly 2025 Closing Moves & Free High Return Stock Watch Alerts - Newser

Dec 04, 2025

Dec 03, 2025

Cognition Therapeutics completes enrollment in expanded access program By Investing.com - Investing.com Nigeria

Dec 03, 2025

Dec 03, 2025

Cognition Therapeutics completes enrollment in expanded access program - Investing.com India

Dec 03, 2025

Dec 03, 2025

Cognition Therapeutics Says Zervimesine Expanded Access Program Reaches Full Enrollment - marketscreener.com

Dec 03, 2025

Dec 03, 2025

Cognition Therapeutics Reaches Full Enrollment in Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies - Yahoo Finance

Dec 03, 2025

Dec 03, 2025

Cognition Therapeutics (CGTX) Stock Analysis Report | Financials & Insights - Benzinga

Dec 03, 2025

Dec 02, 2025

Cognition Therapeutics presents Phase 3 plan for zervimesine in Alzheimer’s - MSN

Dec 02, 2025

Dec 01, 2025

Cognition Therapeutics outlines Phase 3 plans for Alzheimer’s drug By Investing.com - Investing.com Nigeria

Dec 01, 2025

Dec 01, 2025

Cognition Therapeutics outlines Phase 3 plans for Alzheimer’s drug - Investing.com

Dec 01, 2025

Dec 01, 2025

Cognition Therapeutics outlines phase 3 Alzheimer's plan at CTAD - marketscreener.com

Dec 01, 2025

Dec 01, 2025

Cognition Therapeutics Outlines Phase 3 Alzheimer's Plan at CTAD - TradingView

Dec 01, 2025

Dec 01, 2025

Cognition Therapeutics, Inc. Plans to Align with EMA on Alzheimer's Disease Strategy for Zervimesine at February 2026 Meeting - Quiver Quantitative

Dec 01, 2025

Dec 01, 2025

Cognition Therapeutics Presents Phase 3 Plan for Zervimesine (CT1812) in Alzheimer’s Disease at Clinical Trials on Alzheimer’s Disease (CTAD) Conference - marketscreener.com

Dec 01, 2025

Dec 01, 2025

Cognition Therapeutics (NASDAQ: CGTX) maps Phase 3 AD trial after 95% decline slowdown - Stock Titan

Dec 01, 2025

Nov 28, 2025

Cognition Therapeutics Inc Stock Analysis and ForecastConsumer Goods Stocks & Affordable Market Investment - earlytimes.in

Nov 28, 2025

Nov 27, 2025

Cognition Therapeutics Inc. (CGTX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 27, 2025

Nov 24, 2025

Q1 Earnings Forecast for CGTX Issued By B. Riley - MarketBeat

Nov 24, 2025

Nov 23, 2025

Cognition Therapeutics, Inc. (NASDAQ:CGTX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Nov 23, 2025

Nov 21, 2025

Cognition Therapeutics: A High-Stakes Bet On A Single DrugWhy I Hold (NASDAQ:CGTX) - Seeking Alpha

Nov 21, 2025

Nov 21, 2025

B. Riley Securities Reiterates Cognition Therapeutics (CGTX) Buy Recommendation - Nasdaq

Nov 21, 2025

Nov 21, 2025

Cognition Therapeutics (CGTX) Sees Analyst Price Target Boost | CGTX Stock News - GuruFocus

Nov 21, 2025

Nov 21, 2025

B. Riley Raises Price Target on Cognition Therapeutics to $3 From $2, Keeps Buy Rating - marketscreener.com

Nov 21, 2025

Nov 20, 2025

Cognition Therapeutics to Participate in 37th Annual Piper Sandler Healthcare Conference - The Manila Times

Nov 20, 2025

Nov 20, 2025

Cognition Therapeutics, Inc. CEO Lisa Ricciardi to Speak at Annual Piper Sandler Healthcare Conference - Quiver Quantitative

Nov 20, 2025

Nov 20, 2025

Cognition Therapeutics (Nasdaq: CGTX) CEO Talk at 37th Piper Sandler Healthcare Conf - Stock Titan

Nov 20, 2025

Nov 20, 2025

Will Cognition Therapeutics Inc. stock beat EPS estimatesJuly 2025 PostEarnings & Safe Entry Trade Reports - newser.com

Nov 20, 2025

Nov 19, 2025

Can Cognition Therapeutics Inc. stock beat analyst upgradesEarnings Trend Report & AI Enhanced Trading Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

What analyst consensus says on Cognition Therapeutics Inc. stock - newser.com

Nov 19, 2025

Nov 19, 2025

Will Cognition Therapeutics Inc. stock pay special dividendsPortfolio Performance Report & Long-Term Growth Portfolio Plans - newser.com

Nov 19, 2025

Nov 19, 2025

CGTX: HC Wainwright Reiterates Buy Rating and Price Target | CGT - GuruFocus

Nov 19, 2025

Nov 19, 2025

How to use a screener to detect Cognition Therapeutics Inc. breakoutsTrade Volume Summary & High Win Rate Trade Alerts - newser.com

Nov 19, 2025

Nov 18, 2025

Why Cognition Therapeutics Inc. stock appeals to dividend seekersIndex Update & Long-Term Growth Plans - newser.com

Nov 18, 2025